Literature DB >> 5098108

Clues to the life history of carcinoma in situ of the larynx.

A H Miller, H R Fisher.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5098108     DOI: 10.1288/00005537-197109000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  5 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

Review 2.  Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants.

Authors:  Bruce M Wenig
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 3.  Management of laryngeal dysplasia: a review.

Authors:  Maziar Sadri; Jeremy McMahon; Andrew Parker
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-06       Impact factor: 2.503

4.  Cyclin D1 and cancer development in laryngeal premalignancy patients.

Authors:  Vassiliki Papadimitrakopoulou; Julie G Izzo; Diane D Liu; Jeffrey Myers; Tania L Ceron; Jan Lewin; William N William; Anthea Atwell; J Jack Lee; Ann Gillenwater; Adel El-Naggar; Xifeng Wu; Scott M Lippman; Walter N Hittelman; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2009-01

5.  Serial full-thickness excision of dysplastic vocal fold leukoplakia: Diagnostic or therapeutic?

Authors:  Annie Ahn; Li Wang; James C Slaughter; Amy M Nguyen; Robert H Ossoff; David O Francis
Journal:  Laryngoscope       Date:  2015-11-03       Impact factor: 3.325

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.